Home LiteratureArticle Details
PMID: 11500414 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Changes in availability of oxygen accentuate differences in capsular polysaccharide expression by phenotypic variants and clinical isolates of Streptococcus pneumoniae.

Infection and immunity ·Vol. 69 ·No. 9 ·2001-09-00 ·Pages 5430-9

Weiser JN, Bae D, Epino H, Gordon SB, Kapoor M, Zenewicz LA, Shchepetov M

Abstract

Most isolates of Streptococcus pneumoniae are mixed populations of transparent (T) and opaque (O) colony phenotypes. Differences in the production of capsular polysaccharide (CPS) between O and T variants were accentuated by changes in the environmental concentration of oxygen. O variants demonstrated a 5.2- to 10.6-fold increase in amounts of CPS under anaerobic compared to atmospheric growth conditions, while CPS production remained low under all conditions for T variants. Increased amounts of CPS in O compared to T pneumococci were associated with increased expression of cps-encoded proteins. The inhibitory effect of oxygen on expression of CPS in O variants correlated with decreased tyrosine phosphorylation of CpsD, a tyrosine kinase and regulator of CPS synthesis. Modulation of CpsD expression and its activity by tyrosine phosphorylation may allow the pneumococcus to adapt to the requirements of both colonization, where decreased CPS allows for adherence, and bacteremia, where increased CPS may be required to escape from opsonic clearance. In patients with invasive infection, paired isolates from the same patient were shown to have predominantly a T colony phenotype without phosphotyrosine on CpsD when cultured from the nasopharynx, and an O phenotype that phosphorylates CpsD in response to oxygen when cultured from the blood. Differences in the availability of oxygen, therefore, may be a key factor in allowing for the selection of distinct phenotypes in these two host environments.

MeSH Terms
Bacteremia/microbiology Bacterial Capsules/drug effects,metabolism Bacterial Proteins Carrier State/microbiology Galactosyltransferases/genetics,metabolism Gene Expression Regulation, Bacterial Humans Molecular Sequence Data Oxygen/pharmacology Phenotype Phosphorylation Pneumococcal Infections/microbiology Streptococcus pneumoniae/classification,genetics,isolation & purification,metabolism Transcription, Genetic Tyrosine/metabolism
Chemicals
Bacterial Proteins Tyrosine CpsD protein, bacteria Galactosyltransferases Oxygen
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Weiser J N
Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA [email protected].
Bae D
Epino H
Gordon S B
Kapoor M
Zenewicz L A
Shchepetov M
References (40)
40 references, click to expand
  1. The NADH oxidase of Streptococcus pneumoniae: its involvement in competence and virulence.
    Mol Microbiol. 1999 Dec;34(5):1018-28 PMID: 10594826
  2. Relation of virulence of pneumococcal strains for mice to the quantity of capsular polysaccharide formed in vitro.
    J Exp Med. 1950 Jul 1;92(1):1-9 PMID: 15422092
  3. Genetic relationships between clinical isolates of Streptococcus pneumoniae, Streptococcus oralis, and Streptococcus mitis: characterization of "Atypical" pneumococci and organisms allied to S. mitis harboring S. pneumoniae virulence factor-encoding genes.
    Infect Immun. 2000 Mar;68(3):1374-82 PMID: 10678950
  4. Tyrosine phosphorylation of CpsD negatively regulates capsular polysaccharide biosynthesis in streptococcus pneumoniae.
    Mol Microbiol. 2000 Mar;35(6):1431-42 PMID: 10760144
  5. Inhibitory and bactericidal effects of hydrogen peroxide production by Streptococcus pneumoniae on other inhabitants of the upper respiratory tract.
    Infect Immun. 2000 Jul;68(7):3990-7 PMID: 10858213
  6. Differential protein expression in phenotypic variants of Streptococcus pneumoniae.
    Infect Immun. 2000 Aug;68(8):4604-10 PMID: 10899862
  7. Peritoneal culture alters Streptococcus pneumoniae protein profiles and virulence properties.
    Infect Immun. 2000 Oct;68(10):6082-6 PMID: 10992528
  8. Effect of influenza A virus infection on nasopharyngeal colonization and otitis media induced by transparent or opaque phenotype variants of Streptococcus pneumoniae in the chinchilla model.
    Infect Immun. 2001 Jan;69(1):602-6 PMID: 11119562
  9. Molecular characterization of Streptococcus pneumoniae type 4, 6B, 8, and 18C capsular polysaccharide gene clusters.
    Infect Immun. 2001 Mar;69(3):1244-55 PMID: 11179285
  10. Covalent linkage between the capsular polysaccharide and the cell wall peptidoglycan of Streptococcus pneumoniae revealed by immunochemical methods.
    Microb Pathog. 1990 May;8(5):325-34 PMID: 2215183
  11. Loss of capsule expression by Haemophilus influenzae type b results in enhanced adherence to and invasion of human cells.
    Infect Immun. 1991 Apr;59(4):1325-33 PMID: 1672302
  12. Positive transcriptional control of mry regulates virulence in the group A streptococcus.
    Mol Microbiol. 1993 Mar;7(6):893-903 PMID: 8483419
  13. Identification of hydrogen peroxide as a Streptococcus pneumoniae toxin for rat alveolar epithelial cells.
    Infect Immun. 1993 Oct;61(10):4392-7 PMID: 8406830
  14. Effect of type III group B streptococcal capsular polysaccharide on invasion of respiratory epithelial cells.
    Infect Immun. 1993 Nov;61(11):4835-41 PMID: 8406885
  15. Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization.
    Infect Immun. 1994 Jun;62(6):2582-9 PMID: 8188381
  16. Relationship between colonial morphology and adherence of Streptococcus pneumoniae.
    Infect Immun. 1995 Mar;63(3):757-61 PMID: 7868244
  17. Genomic organization of the Klebsiella pneumoniae cps region responsible for serotype K2 capsular polysaccharide synthesis in the virulent strain Chedid.
    J Bacteriol. 1995 Apr;177(7):1788-96 PMID: 7896702
  18. Middle ear gas composition and middle ear aeration.
    Ann Otol Rhinol Laryngol. 1995 May;104(5):369-73 PMID: 7747907
  19. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor.
    Nature. 1995 Oct 5;377(6548):435-8 PMID: 7566121
  20. Phase-shift of polysaccharide capsule expression in group B streptococci, type III.
    Microb Pathog. 1995 Jun;18(6):401-15 PMID: 8551943
  21. Capsule phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal disease.
    Mol Microbiol. 1996 Jun;20(6):1211-20 PMID: 8809773
  22. Gas composition of the human nose and nasopharyngeal space.
    Acta Otolaryngol. 1996 Jan;116(1):82-4 PMID: 8820356
  23. Identification, cloning, and sequencing of the immunoglobulin A1 protease gene of Streptococcus pneumoniae.
    Infect Immun. 1996 Oct;64(10):3967-74 PMID: 8926056
  24. Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection.
    J Clin Invest. 1996 Nov 1;98(9):1954-8 PMID: 8903312
  25. Pneumococcal bacteremia in hospitalized Israeli adults: epidemiology and resistance to penicillin. Israeli Adult Pneumococcal Bacteremia Group.
    Clin Infect Dis. 1997 Jun;24(6):1164-8 PMID: 9195076
  26. The Staphylococcus aureus allelic genetic loci for serotype 5 and 8 capsule expression contain the type-specific genes flanked by common genes.
    Microbiology. 1997 Jul;143 ( Pt 7):2395-405 PMID: 9245821
  27. Middle ear gas composition in pathologic conditions: mass spectrometry in otitis media with effusion and atelectasis.
    Ann Otol Rhinol Laryngol. 1997 Sep;106(9):743-5 PMID: 9302904
  28. Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae.
    Mol Microbiol. 1997 Sep;25(5):819-29 PMID: 9364908
  29. Characterization of a bacterial gene encoding an autophosphorylating protein tyrosine kinase.
    Gene. 1997 Dec 19;204(1-2):259-65 PMID: 9434192
  30. Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae.
    J Infect Dis. 1998 Feb;177(2):368-77 PMID: 9466523
  31. Phase variation in colony opacity by Streptococcus pneumoniae.
    Microb Drug Resist. 1998 Summer;4(2):129-35 PMID: 9651000
  32. Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway.
    J Clin Invest. 1998 Jul 15;102(2):347-60 PMID: 9664076
  33. Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus.
    Mol Microbiol. 1998 Oct;30(1):209-19 PMID: 9786197
  34. Relationship between cell surface carbohydrates and intrastrain variation on opsonophagocytosis of Streptococcus pneumoniae.
    Infect Immun. 1999 May;67(5):2327-33 PMID: 10225891
  35. Cells of Escherichia coli contain a protein-tyrosine kinase, Wzc, and a phosphotyrosine-protein phosphatase, Wzb.
    J Bacteriol. 1999 Jun;181(11):3472-7 PMID: 10348860
  36. Protein tyrosine kinases in bacterial pathogens are associated with virulence and production of exopolysaccharide.
    EMBO J. 1999 Jun 15;18(12):3241-8 PMID: 10369665
  37. Effect of intrastrain variation in the amount of capsular polysaccharide on genetic transformation of Streptococcus pneumoniae: implications for virulence studies of encapsulated strains.
    Infect Immun. 1999 Jul;67(7):3690-2 PMID: 10377162
  38. Molecular characterization of type-specific capsular polysaccharide biosynthesis genes of Streptococcus agalactiae type Ia.
    J Bacteriol. 1999 Sep;181(17):5176-84 PMID: 10464185
  39. Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity.
    Clin Infect Dis. 1999 Aug;29(2):281-8 PMID: 10476727
  40. A genomic analysis of two-component signal transduction in Streptococcus pneumoniae.
    Mol Microbiol. 2000 Feb;35(3):566-76 PMID: 10672179
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
2001-09-00
Pages
5430-9
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC98654
Subset
IM
Grants
NIAID NIH HHS · R01 AI044231 · United States
NIAID NIH HHS · R21 AI044231 · United States
NIAID NIH HHS · AI38436 · United States
NIAID NIH HHS · AI44231 · United States
Databases
GENBANK
AF359247
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]